KX2-391

Biorbyt

KX2-391 [897016-82-9]

16

897016-82-9

Research Use Only

C26H29N3O3

431.5268

KX2-391, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.

O1C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])OC2C([H])=C([H])C(=C([H])C=2[H])C2=C([H])N=C(C([H])=C2[H])C([H])([H])C(N([H])C([H])([H])C2C([H])=C([H])C([H])=C([H])C=2[H])=O)C([H])([H])C1([H])[H]

12352200